The Depression Inventory Development Workgroup: A Collaborative, Empirically Driven Initiative to Develop a New Assessment Tool for Major Depressive Disorder
Anthony L. Vaccarino, PhD, Kenneth R. Evans, PhD, Amir H. Kalali, MD, Sidney H. Kennedy, MD, FRCPC, Nina Engelhardt, PhD, Benico N. Frey, MD, MSc, PhD, John H. Greist, MD, Kenneth A. Kobak, PhD, Raymond W. Lam, MD, FRCPC, Glenda MacQueen, MD, PhD, FRCPC, Roumen Milev, MD, PhD, FRCPC, FRCPsych, Franca M. Placenza, PhD, Arun V. Ravindran, MB, MSc, PhD, FRCPC, FRCPsych, David V. Sheehan, MD, MBA, Terrence Sills, PhD, and Janet B. Williams, PhD
The Depression Inventory Development project is an initiative of the International Society for CNS Drug Development whose goal is to develop a comprehensive and psychometrically sound measurement tool to be utilized as a primary endpoint in clinical trials for major depressive disorder. Using an iterative process between field testing and psychometric analysis and drawing upon expertise of international researchers in depression, the Depression Inventory Development team has established an empirically driven and collaborative protocol for the creation of items to assess symptoms in major depressive disorder. Depression-relevant symptom clusters were identified based on expert clinical and patient input. In addition, as an aid for symptom identification and item construction, the psychometric properties of existing clinical scales (assessing depression and related indications) were evaluated using blinded datasets from pharmaceutical antidepressant drug trials. A series of field tests in patients with major depressive disorder provided the team with data to inform the iterative process of scale development. We report here an overview of the Depression Inventory Development initiative, including results of the third iteration of items assessing symptoms related to anhedonia, cognition, fatigue, general malaise, motivation, anxiety, negative thinking, pain and appetite. The strategies adopted from the Depression Inventory Development program, as an empirically driven and collaborative process for scale development, have provided the foundation to develop and validate measurement tools in other therapeutic areas as well.
Source:Vaccarino, AL, Evans, KR, Kalali, AH, Kennedy, SH, Engelhardt, N, Frey, BN, et al. The Depression Inventory Development Workgroup: A Collaborative, Empirically Driven Initiative to Develop a New Assessment Tool for Major Depressive Disorder. Innov Clin Neurosci. 2016;13(9-10):20-31.